XORTX Therapeutics Inc. Common Stock (XRTX) is a publicly traded Healthcare sector company. As of May 19, 2026, XRTX trades at $2.53 with a market cap of $4.01M and a P/E ratio of 0.00. XRTX moved +0.00% today. Year to date, XRTX is -8.77%; over the trailing twelve months it is -51.40%. Its 52-week range spans $1.73 to $12.55. Rallies surfaces XRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own XRTX include Citadel Advisors. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for XORTX Therapeutics Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $2.53 |
| Market Cap | $4.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.55 |
| 52-Week Low | $1.73 |
| Volume | 3.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
XRTX analyst coverage data. Average price target: $0.00.